ALBT stock icon

Avalon GloboCare

0.1881 USD
-0.0119
5.95%
Updated Oct 22, 10:48 AM EDT
1 day
-5.95%
5 days
-7.97%
1 month
-8.69%
3 months
-53.78%
6 months
-34.23%
Year to date
-59.98%
1 year
-69.32%
5 years
-98.82%
 

About: Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Employees: 6

0
Funds holding %
of 6,740 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

272% more capital invested

Capital invested by funds: $32K [Q1] → $119K (+$87.1K) [Q2]

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

30% more funds holding

Funds holding: 10 [Q1] → 13 (+3) [Q2]

1.38% more ownership

Funds ownership: 0.91% [Q1] → 2.29% (+1.38%) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for ALBT.

Financial journalist opinion

Charts implemented using Lightweight Charts™